Intravitreal Administration of HA-1077, a ROCK Inhibitor, Improves Retinal Function in a Mouse Model of Huntington Disease
Open Access
- 11 February 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (2), e56026
- https://doi.org/10.1371/journal.pone.0056026
Abstract
Huntington disease (HD) is an inherited neurodegenerative disease that affects multiple brain regions. It is caused by an expanded polyglutamine tract in huntingtin (Htt). The development of therapies for HD and other neurodegenerative diseases has been hampered by multiple factors, including the lack of clear therapeutic targets, and the cost and complexity of testing lead compounds in vivo. The R6/2 HD mouse model is widely used for pre-clinical trials because of its progressive and robust neural dysfunction, which includes retinal degeneration. Profilin-1 is a Htt binding protein that inhibits Htt aggregation. Its binding to Htt is regulated by the rho-associated kinase (ROCK), which phosphorylates profilin at Ser-137. ROCK is thus a therapeutic target in HD. The ROCK inhibitor Y-27632 reduces Htt toxicity in fly and mouse models. Here we characterized the progressive retinopathy of R6/2 mice between 6–19 weeks of age to determine an optimal treatment window. We then tested a clinically approved ROCK inhibitor, HA-1077, administered intravitreally via liposome-mediated drug delivery. HA-1077 increased photopic and flicker ERG response amplitudes in R6/2 mice, but not in wild-type littermate controls. By targeting ROCK with a new inhibitor, and testing its effects in a novel in vivo model, these results validate the in vivo efficacy of a therapeutic candidate, and establish the feasibility of using the retina as a readout for CNS function in models of neurodegenerative disease.Keywords
This publication has 42 references indexed in Scilit:
- AAV-Mediated Cone Rescue in a Naturally Occurring Mouse Model of CNGA3-AchromatopsiaPLOS ONE, 2012
- Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 miceNeurobiology of Disease, 2009
- A Rapid Cellular FRET Assay of Polyglutamine Aggregation Identifies a Novel InhibitorNeuron, 2003
- Polyglutamine-Expanded Ataxin-7 Antagonizes CRX Function and Induces Cone-Rod Dystrophy in a Mouse Model of SCA7Neuron, 2001
- Clinical Effect of Fasudil Hydrochloride for Cerebral Vasospasm Following Subarachnoid HemorrhageActa neurochirurgica. Supplement, 2001
- Variability in Rate of Cone Degeneration in the Retinal Degeneration (rd/rd) MouseExperimental Eye Research, 1997
- Retinal degeneration in the nervous mutant mouse. I. Light microscopic cytopathology and changes in the interphotoreceptor matrixJournal of Comparative Neurology, 1993
- Retinal degeneration in the pcd cerebellar mutant mouse. I. Light microscopic and autoradiographio analysisJournal of Comparative Neurology, 1982
- Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopyJournal of Comparative Neurology, 1979
- Differential effect of the rd mutation on rods and cones in the mouse retina.1978